☆ 4.6 Article

Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trials

LANCET GASTROENTEROLOGY & HEPATOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Gastroenterology & Hepatology

Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial

Jyh-Ming Liou et al.

Summary: This study compared the effectiveness, tolerability, and short-term and long-term effects of levofloxacin-based sequential quadruple therapy and bismuth-based quadruple therapy as second-line regimens for Helicobacter pylori eradication. The results showed no significant difference between the two therapies in terms of eradication rate, antibiotic resistome, fecal microbiota composition, and metabolic parameters.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2023)

添加到收藏夹

Editorial Material Gastroenterology & Hepatology

Antimicrobial Susceptibility Testing for Helicobacter pylori Is Now Widely Available: When, How, Why

David Y. Graham et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Cross-roads for meta-analysis and network meta-analysis of H. pylori therapy

David Y. Graham et al.

Summary: Helicobacter pylori infections are a global health issue, with antimicrobial therapy effectiveness hindered by resistance. Traditional and network meta-analyses have limitations in guiding treatment, necessitating new approaches. Treatment should be based on antimicrobial stewardship, ensuring cure rates exceed 90%, and considering geographical and host genetic heterogeneity.

GUT (2022)

添加到收藏夹

Article Infectious Diseases

The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis

Timothy M. Walker et al.

Summary: This study aimed to generate a WHO-endorsed catalogue of mutations for drug resistance prediction in Mycobacterium tuberculosis complex (MTBC) and provide a global standard for interpreting molecular information. The research analyzed MTBC isolates from 45 countries and identified mutations associated with resistance to different antituberculosis drugs. The findings can encourage the implementation of molecular diagnostics by national tuberculosis programs.

LANCET MICROBE (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report

Peter Malfertheiner et al.

Summary: Helicobacter pylori infection is recognized as an infectious disease and requires optimized management to prevent complications and gastric cancer. Continuous updates in treatment strategies and testing methods are necessary due to rising antibiotic resistance and the impact on gut microbiota.

GUT (2022)

添加到收藏夹

Review Immunology

Prevalence of antibiotic heteroresistance associated with Helicobacter pylori infection: A systematic review and meta-analysis br

Masoud Keikha et al.

Summary: This study evaluated the prevalence of heteroresistance H. pylori infection and found varying resistance rates to different antibiotics. There were differences in antimicrobial susceptibility among strains isolated from different anatomical sites of the stomach. In developing countries, heteroresistance was mainly due to infection with multiple H. pylori strains, while in developed countries it was due to microevolution of a single strain under antibiotic pressure.

MICROBIAL PATHOGENESIS (2022)

添加到收藏夹

Review Microbiology

Heteroresistance to clarithromycin and metronidazole in patients with a Helicobacter pylori infection: a systematic review and meta-analysis

Ebrahim Kouhsari et al.

Summary: This meta-analysis provides comprehensive data on the prevalence of metronidazole and clarithromycin heteroresistance in H. pylori positive samples. The study finds that approximately 7% of samples show heteroresistance to clarithromycin, and approximately 14% show heteroresistance to metronidazole.

ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2022)

添加到收藏夹

Review Microbiology

Empirical vs. Susceptibility-Guided Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis

Olga P. Nyssen et al.

Summary: The meta-analysis comparing empirical vs. susceptibility-guided treatment of H. pylori infection showed that there was no demonstrated benefit of susceptibility-guided treatment over empirical treatment, whether in first-line (with updated quadruple regimens) or in rescue therapies.

FRONTIERS IN MICROBIOLOGY (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications

Evariste Tshibangu-Kabamba et al.

Summary: Helicobacter pylori is a major human pathogen with increasing antibiotic resistance posing a serious threat to human health. The resistance mechanisms include single drug resistance, multidrug resistance, and heteroresistance, primarily related to mutational changes and target-mediated mechanisms. Further research is needed to explore additional biological attributes driving drug resistance in H. pylori for better treatment outcomes.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides

Eva Kocsmar et al.

Summary: Clarithromycin, a macrolide antibiotic, is commonly used to treat Helicobacter pylori infection. The study by Kocsmar et al. on clarithromycin resistance and previous macrolide consumption in 4,744 H. pylori-infected patients sheds light on the sources of primary resistant cases and the impact of prior macrolide consumption for non-eradication purposes.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Helicobacter pylori heteroresistance to clarithromycin in adults-New data by in situ detection and improved concept

Eva Kocsmar et al.

HELICOBACTER (2020)

添加到收藏夹

Article Medicine, General & Internal

Helicobacter pylori Eradication According to Sequencing-Based 23S Ribosomal RNA Point Mutation Associated with Clarithromycin Resistance

Seung In Seo et al.

JOURNAL OF CLINICAL MEDICINE (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus

Jyh-Ming Liou et al.

GUT (2020)

添加到收藏夹

Review Immunology

Perspective for Precision Medicine for Tuberculosis

Christoph Lange et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Microbiology

Helicobacter pylori Mutations Detected by Next-Generation Sequencing in Formalin-Fixed, Paraffin-Embedded Gastric Biopsy Specimens Are Associated with Treatment Failure

Behtash G. Nezami et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Helicobacter pylori eradication rates with concomitant and tailored therapy based on 23S rRNA point mutation: A multicenter randomized controlled trial

Sungmoon Ong et al.

HELICOBACTER (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection

Jyh-Ming Liou et al.

GASTROENTEROLOGY (2018)

添加到收藏夹

Review Gastroenterology & Hepatology

A systematic review and meta-analysis of genotypic methods for detecting antibiotic resistance in Helicobacter pylori

You-hua Wang et al.

HELICOBACTER (2018)

添加到收藏夹

Article Infectious Diseases

14 day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: a multicentre, non-inferiority, randomized trial

Jyh-Ming Liou et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)

添加到收藏夹

Article Infectious Diseases

Impact of amoxicillin resistance on the efficacy of amoxicillin-containing regimens for Helicobacter pylori eradication: analysis of five randomized trials

Mei-Jyh Chen et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)

添加到收藏夹

Editorial Material Gastroenterology & Hepatology

Noninvasive molecular analysis of Helicobacter pylori: Is it time for tailored first-line therapy?

Enzo Ierardi et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Hp-normogram (normo-graham) for Assessing the Outcome of H-pylori Therapy: Effect of Resistance, Duration, and CYP2C19 Genotype

David Y. Graham

HELICOBACTER (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Molecular Approaches to Identify Helicobacter pylori Antimicrobial Resistance

Francis Megraud et al.

GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2015)

添加到收藏夹

Article Infectious Diseases

Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial

Jyh-Ming Liou et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)

添加到收藏夹

Article Immunology

Eradication of Helicobacter pylori According to 23S Ribosomal RNA Point Mutations Associated With Clarithromycin Resistance

Hyun Jeong Lee et al.

JOURNAL OF INFECTIOUS DISEASES (2013)

添加到收藏夹

Article Medicine, General & Internal

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial

Jyh-Ming Liou et al.

LANCET (2013)

添加到收藏夹

Article Microbiology

Genotypic Resistance in Helicobacter pylori Strains Correlates with Susceptibility Test and Treatment Outcomes after Levofloxacin- and Clarithromycin-Based Therapies

Jyh-Ming Liou et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)

添加到收藏夹

Review Gastroenterology & Hepatology

Rescue regimens after Helicobacter pylori treatment failure

Javier P. Gisbert

WORLD JOURNAL OF GASTROENTEROLOGY (2008)

添加到收藏夹

Review Microbiology

Helicobacter pylori detection and antimicrobial susceptibility testing

Francis Megraud et al.

CLINICAL MICROBIOLOGY REVIEWS (2007)

添加到收藏夹

Article Medicine, General & Internal

Clarithromycin-resistant genotypes and eradication of Helicobacter pylori

V De Francesco et al.

ANNALS OF INTERNAL MEDICINE (2006)

添加到收藏夹

Review Gastroenterology & Hepatology

H pylori antibiotic resistance:: prevalence, importance, and advances in testing

F Mégraud

GUT (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.